Axovant Sciences Ltd. (NASDAQ:AXON) marched up 19.35% compared to a 52-week low price of $0.93. The shares were last seen trading -3.48% lower, taking the closing price at $1.11 on 01/11/2019. At recent session, the prices were hovering between $1.1 and $1.21. This company shares are 296.4% off its target price of $4.4 and the current market capitalization stands at $178.6M. The recent change has given its price a -28.17% deficit over SMA 50 and -83.16% deficit over its 52-week high. The stock witnessed -10.48% declines, -46.89% declines and -55.6% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found AXON’s volatility during a week at 10.95% and during a month it has been found around 10.37%.Axovant Sciences Ltd. (AXON) Top Holders
Institutional investors currently hold around $10 million or 18.8% in AXON stock. Look at its top three institutional owners. Renaissance Technologies Llc owns $2.32 million in Axovant Sciences Ltd., which represents roughly 1.3% of the company’s market cap and approximately 23.22% of the institutional ownership. Similar statistics are true for the second largest owner, Blackrock Inc., which owns 1,424,710 shares of the stock are valued at $1.58 million. The third largest holder is Primecap Management Co/Ca/, which currently holds $1.2 million worth of this stock and that ownership represents nearly 0.67% of its market capitalization.Axovant Sciences Ltd. 13F Filings
At the end of September reporting period, 19 institutional holders increased their position in Axovant Sciences Ltd. (NASDAQ:AXON) by some 1,327,521 shares, 42 decreased positions by 3,347,505 and 17 held positions by 4,712,163. That puts total institutional holdings at 9,387,189 shares, according to SEC filings. The stock grabbed 7 new institutional investments totaling 45,250 shares while 18 institutional investors sold out their entire positions totaling 910,658 shares.Axovant Sciences Ltd. (NASDAQ:AXON) Insider Trades
Multiple company employees have indulged in significant insider trading. Axovant Sciences Ltd. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that 10% Owner Viking Global Investors Lp has acquired 10,000,000 shares of Axovant Sciences Ltd. (AXON) in trading session dated Dec. 18, 2018. These shares are worth $10,000,000 and were traded at $1 each. The SEC filing shows that Viking Global Performance Llc performed a purchase of 10,000,000 shares. The 10% Owner added these shares by way of transaction on Dec. 18, 2018. The company’s shares were assimilated at $1 per share worth to an investment of some $10,000,000 on account of Viking Global Performance Llc.
10% Owner, Lo Andrew, purchased 10,000,000 common shares of Axovant Sciences Ltd. (AXON) in the open market. In a transaction dated Dec. 18, 2018, the shares were bought at an average price of $1, giving away a sum of $10,000,000. After this purchase, 99,285,714 common shares of AXON are directly owned by the insider, with total stake valued at $110,207,143.
In the transaction dated Dec. 18, 2018, the great number of shares acquired came courtesy the 10% Owner; Svf Investments (Uk) Ltd added a total of 10,000,000 shares at an average price of $1, amounting to approximately $10,000,000. The insider now directly owns 99,285,714 shares worth $110,207,143.Axovant Sciences Ltd. (AXON) Analyst Guide
Several analysts have released their opinion on Axovant Sciences Ltd. (NASDAQ:AXON), with 1 analysts believing it is a strong buy. Whereas 3 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.33 average brokerage recommendation.